San Francisco (1)

Low Grade Glioma (1)

Mixed Oligoastrocytomas (1)

Oligodendrogliomas (1)

World Health Organization (WHO) Grade II Astrocytomas (1)

Terminated (1)

phase 2 (1)

University of California, San Francisco (1)

Novartis (1)

everolimus (1)

temozolomide (1)

drug (1)

Other (1)

Interventional (1)

world health organization (who) grade ii astrocytomas

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

Nov 3, 2021